Rare Disease UK

Rare Disease UK
Name	Rare Disease UK
Formation	2009
Type	Advocacy group
Headquarters	United Kingdom
Parent organization	Genetic Alliance UK
Purpose	Patient advocacy for rare conditions

Rare Disease UK is a UK-based patient-led advocacy group focused on improving diagnosis, care, and support for people with uncommon health conditions. Founded as part of a larger patient-advocacy network, the organisation works with healthcare providers, regulators, funders, and legislators to influence policy, research funding, and service delivery. It engages with charities, professional bodies, and international agencies to amplify voices of patients affected by rare conditions.

History

Rare Disease UK originated within Genetic Alliance UK as a programme to coordinate patient organisations and amplify patient voices on policy matters. It was established during a period when policy frameworks such as the UK National Health Service reform debates and European initiatives like the 2011 Council Recommendation on an Action in the Field of Rare Diseases heightened attention to rare conditions. Early collaborations involved charities including Muscular Dystrophy UK, Cystic Fibrosis Trust, and Mencap, and it engaged with regulatory bodies such as the Medicines and Healthcare products Regulatory Agency and funders like the National Institute for Health and Care Excellence. The organisation has participated in consultations related to landmark documents and processes including national strategies influenced by the National Institute for Health and Care Excellence guidance, and worked alongside research funders such as the Medical Research Council and Wellcome Trust to highlight unmet needs.

Mission and Objectives

The group's mission emphasises improving diagnosis, treatment access, and social support for people living with rare conditions through advocacy, policy work, and partnership. Objectives include influencing health policy in institutions such as the Department of Health and Social Care, shaping commissioning structures like the NHS England specialised services framework, and securing equitable access to therapies assessed by bodies such as NICE. It aims to strengthen patient representation in advisory forums including the Health Research Authority and national advisory panels, and to support charities, voluntary groups, and patient networks like Rare Disease Day organisers in raising public and professional awareness.

Campaigns and Advocacy

Rare Disease UK has led and contributed to national campaigns on themes such as timely diagnosis, newborn screening, and access to orphan medicinal products approved by regulators including the European Medicines Agency and Medicines and Healthcare products Regulatory Agency. Campaign activities have intersected with initiatives like Rare Disease Day and policy milestones such as the development of national rare disease strategies modeled on European frameworks. The organisation has coordinated with disability rights advocates, including Scope (charity) and Contact a Family, and has engaged with parliamentary processes including Select Committees and MPs from parties represented at the Palace of Westminster to lobby for legislative and funding commitments.

Services and Support for Patients

Through partnerships with patient groups such as Genetic Alliance UK partners and condition-specific charities like Brittle Bone Society and Action for Pulmonary Fibrosis, the organisation provides tools for patient engagement, guidance on navigating specialised care pathways delivered by NHS England centres, and resources for involvement in research governance overseen by bodies such as the Health Research Authority. It facilitates networks connecting patients with clinical specialists based at institutions such as Great Ormond Street Hospital, academic centres including University College London and University of Oxford, and research consortia working with the Medical Research Council. Support also includes advocacy training, involvement in priority-setting partnerships allied to the James Lind Alliance, and signposting to support services offered by charities like Turn2Us.

Policy Influence and Partnerships

The organisation has influenced policy through consultations with national agencies such as NICE, NHS England, and the Department of Health and Social Care, and has partnered with research funders and academic networks including the National Institute for Health Research and university research groups. Strategic partnerships have extended to international organisations like EURORDIS and collaborative platforms such as the European Reference Networks, enabling cross-border policy dialogue. The organisation has engaged with pharmaceutical stakeholders, regulators such as the European Medicines Agency, and patient-advocacy coalitions to shape frameworks for access to orphan drugs and to contribute to reimbursement discussions involving NICE technology appraisal processes.

Research and Awareness Initiatives

Rare Disease UK supports and promotes research priorities developed with academics at institutions like University of Cambridge, King's College London, and research funders including the Wellcome Trust and NIHR. It has participated in awareness campaigns aligned with international observances such as Rare Disease Day and educational outreach involving professional bodies like the Royal College of Paediatrics and Child Health and the Royal College of Physicians. The organisation contributes to studies on patient-reported outcomes, registries coordinated with clinical networks at centres including Great Ormond Street Hospital and university hospitals, and collaborates with charities such as Action for ME and BASIS to improve data collection and research translation.

Category:Health charities in the United Kingdom Category:Rare disease organizations